Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles, California University of California San Diego Moores Cancer Center, San Diego, California Moffitt Cancer Center, Tampa, Florida Massachusetts General Hospital, Boston, Massachusetts NYU Langone Health, New York, New York Columbia University Irving Medical Center, New York, New York Sarah Cannon Research Institute at Mary Crowley, Dallas, Texas The University of Texas MD Anderson Cancer Center, Houston, Texas NEXT Oncology, San Antonio, Texas Huntsman Cancer Institute, Salt Lake City, Utah Fred Hutchinson Cancer Center, Seattle, Washington